{"transactions":[{"id":749840,"issuer":{"id":7770,"kind":"organization","name":"Medicus Pharma Ltd.","symbol":"MDCX"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-04T20:00:21.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year."}],"balance_after":50000,"derivative":{"exercise_price":0.36,"expiration_date":"2031-06-03","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950142-26-001631","document":"es260786882_4-ashton.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997296/000095014226001631/es260786882_4-ashton.xml","form_type":"4"}},{"id":823085,"issuer":{"id":7770,"kind":"organization","name":"Medicus Pharma Ltd.","symbol":"MDCX"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-01T23:03:56.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":0.5,"exercise_date":"2027-03-26","expiration_date":"2031-03-27","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950142-26-001021","document":"es260758758_4-ashton.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997296/000095014226001021/es260758758_4-ashton.xml","form_type":"4"}},{"id":963321,"issuer":{"id":7770,"kind":"organization","name":"Medicus Pharma Ltd.","symbol":"MDCX"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-18T21:06:34.000Z","date":"2025-12-16","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year."}],"balance_after":25000,"derivative":{"exercise_price":1.8,"expiration_date":"2030-12-16","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950142-25-003229","document":"es250717256_4-ashton.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1997296/000095014225003229/es250717256_4-ashton.xml","form_type":"4"}},{"id":1082272,"issuer":{"id":7770,"kind":"organization","name":"Medicus Pharma Ltd.","symbol":"MDCX"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-24T21:10:50.000Z","date":"2025-07-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on July 22, 2025. The option is scheduled to vest quarterly in four equal installments over one year."}],"balance_after":25000,"derivative":{"exercise_price":3.08,"expiration_date":"2030-07-22","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950142-25-002010","document":"es250658434_4-ashton.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1997296/000095014225002010/es250658434_4-ashton.xml","form_type":"4"}},{"id":1545539,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-09T01:25:34.000Z","date":"2024-04-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27229,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0.74,"underlying":"Common Stock","underlying_shares":27229},"source":{"system":"sec-edgar","filing":"0001104659-24-044888","document":"tm2411350-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000110465924044888/tm2411350-1_4seq1.xml","form_type":"4"}},{"id":1545538,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-09T01:25:34.000Z","date":"2024-04-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":118182,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0.8,"underlying":"Common Stock","underlying_shares":118182},"source":{"system":"sec-edgar","filing":"0001104659-24-044888","document":"tm2411350-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000110465924044888/tm2411350-1_4seq1.xml","form_type":"4"}},{"id":1545537,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-09T01:25:34.000Z","date":"2024-04-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":73620,"price":1.1,"value":80982.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units granted under an Issuer equity plan (\"RSUs\") granted to the Reporting Person. Each RSU represented a contingent right to receive one Share upon vesting of the RSU. Pursuant to the terms of the Merger Agreement, each outstanding RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each RSU then outstanding was cancelled and converted into a cash payment equal to the product of (A) the total number of Shares then underlying such RSU multiplied by (B) the Offer Amount, without interest and subject to any withholding of taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-044888","document":"tm2411350-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000110465924044888/tm2411350-1_4seq1.xml","form_type":"4"}},{"id":1545536,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-09T01:25:34.000Z","date":"2024-04-08","kind":"other","planned":false,"acquired":false,"shares":190002,"price":1.1,"value":209002.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 28, 2024, by and among the Issuer, CoreRx, Inc., a Florida corporation (\"Parent\") and Cane Merger Sub, Inc., a Pennsylvania corporation and a wholly owned Subsidiary of Parent (\"Merger Sub\"), Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of April 8, 2024 (the \"Effective Time\") with the Issuer surviving the merger. At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $1.10 per Share in cash (the \"Offer Amount\"), subject to any applicable withholding taxes and without interest."}],"balance_after":73620,"source":{"system":"sec-edgar","filing":"0001104659-24-044888","document":"tm2411350-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000110465924044888/tm2411350-1_4seq1.xml","form_type":"4"}},{"id":1795258,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-28T20:33:43.000Z","date":"2023-08-28","kind":"purchase","planned":false,"acquired":true,"shares":22222,"price":0.455,"value":10111.01,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4549 to $0.455, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":263622,"source":{"system":"sec-edgar","filing":"0001062993-23-017169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000106299323017169/form4.xml","form_type":"4"}},{"id":1819781,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-01T17:13:40.000Z","date":"2023-07-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Stock options of the Issuer (the \"Company Options\") were canceled in the merger and (i) if the Company Option had an exercise price less than the Upfront Consideration, it was exchanged for (1) common stock of the Acquiror with a value equal to the quotient of (A) the product of (x) the total number of common stock of Issuer underlying the Company Option multiplied by (y) the excess, if any, of the value of the Upfront Consideration over the exercise price of such Company Option, divided by (B) the average of the daily volume-weighted average price per share of the common stock of Acquiror calculated based on the ten (10) consecutive trading days ending two trading days prior to the date of the Merger Agreement and (2) a number of CVRs equal to the number of shares of common stock of the Issuer underlying such Company Option, (ii) if the Company Option had an exercise price equal to or greater than the Upfront Consideration and less than the Merger Consideration,"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) it was exchanged for a number of CVRs equal to the number of common stock of the Issuer underlying such Company Option (reduced by the amount that the exercise price exceeds the Upfront Consideration) and (iii) if the Company Option had an exercise price equal to or greater than the Merger Consideration, it was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options of the Issuer (the \"Company Options\") were canceled in the merger and (i) if the Company Option had an exercise price less than the Upfront Consideration, it was exchanged for (1) common stock of the Acquiror with a value equal to the quotient of (A) the product of (x) the total number of common stock of Issuer underlying the Company Option multiplied by (y) the excess, if any, of the value of the Upfront Consideration over the exercise price of such Company Option, divided by (B) the average of the daily volume-weighted average price per share of the common stock of Acquiror calculated based on the ten (10) consecutive trading days ending two trading days prior to the date of the Merger Agreement and (2) a number of CVRs equal to the number of shares of common stock of the Issuer underlying such Company Option, (ii) if the Company Option had an exercise price equal to or greater than the Upfront Consideration and less than the Merger Consideration,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) it was exchanged for a number of CVRs equal to the number of common stock of the Issuer underlying such Company Option (reduced by the amount that the exercise price exceeds the Upfront Consideration) and (iii) if the Company Option had an exercise price equal to or greater than the Merger Consideration, it was canceled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options of the Issuer (the \"Company Options\") were canceled in the merger and (i) if the Company Option had an exercise price less than the Upfront Consideration, it was exchanged for (1) common stock of the Acquiror with a value equal to the quotient of (A) the product of (x) the total number of common stock of Issuer underlying the Company Option multiplied by (y) the excess, if any, of the value of the Upfront Consideration over the exercise price of such Company Option, divided by (B) the average of the daily volume-weighted average price per share of the common stock of Acquiror calculated based on the ten (10) consecutive trading days ending two trading days prior to the date of the Merger Agreement and (2) a number of CVRs equal to the number of shares of common stock of the Issuer underlying such Company Option, (ii) if the Company Option had an exercise price equal to or greater than the Upfront Consideration and less than the Merger Consideration,"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"(Continued from Footnote 2) it was exchanged for a number of CVRs equal to the number of common stock of the Issuer underlying such Company Option (reduced by the amount that the exercise price exceeds the Upfront Consideration) and (iii) if the Company Option had an exercise price equal to or greater than the Merger Consideration, it was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.13,"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-23-017675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000089924323017675/doc4.xml","form_type":"4"}},{"id":1819780,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2023-08-01T17:13:40.000Z","date":"2023-07-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":67660,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 24, 2023, by and among the Issuer, Assertio Holdings, Inc., a Delaware corporation (\"Acquiror\"), and Spade Merger Sub 1, Inc., a Delaware corporation and a wholly owned subsidiary of Acquiror, in exchange for consideration of (a) 0.1783 of a share of the common stock of Acquiror and cash in lieu of fractional shares (the \"Upfront Consideration\") and (b) a contingent value right (\"CVR\") to receive up to an additional $0.20 per common share (subject to adjustment), payable in cash or common stock of Acquiror at the election of Acquiror, upon the achievement of certain milestones, (the Upfront Consideration plus one CVR, collectively, the \"Merger Consideration\") on the effective date of the merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-017675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000089924323017675/doc4.xml","form_type":"4"}},{"id":1884496,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-19T20:56:43.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":27229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in full on May 17, 2024, subject to continued service with the Company."}],"balance_after":27229,"derivative":{"exercise_price":0.74,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":27229},"source":{"system":"sec-edgar","filing":"0001062993-23-011845","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000106299323011845/form4.xml","form_type":"4"}},{"id":1884495,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:56:43.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":73620,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These restricted stock units will vest in full on May 17, 2024, subject to continued service with the Company. Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":241400,"source":{"system":"sec-edgar","filing":"0001062993-23-011845","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000106299323011845/form4.xml","form_type":"4"}},{"id":2168318,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-02T16:00:31.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the aggregate amount of option shares shall vest on each of August 31, 2023, 2024 and 2025, respectively."}],"balance_after":75000,"derivative":{"exercise_price":1.13,"expiration_date":"2032-08-31","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-22-048461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919122048461/doc4.xml","form_type":"4"}},{"id":2168317,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2022-09-02T16:00:31.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on August 31, 2022. One hundred percent (100%) of the total number of RSUs granted vest on the earlier of (i) June 22, 2023 or (ii) the date of the Company's 2023 Annual Meeting of Stockholders."}],"balance_after":67660,"source":{"system":"sec-edgar","filing":"0001209191-22-048461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919122048461/doc4.xml","form_type":"4"}},{"id":2224655,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2022-06-22T21:20:14.000Z","date":"2022-06-21","kind":"sale","acquired":false,"shares":4283,"price":0.785,"value":3362.155,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer."}],"balance_after":42660,"source":{"system":"sec-edgar","filing":"0001209191-22-038806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919122038806/doc4.xml","form_type":"4"}},{"id":2227677,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T20:13:51.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":39473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") is the economic equivalent of one share of Baudax Bio, Inc. (the \"Company\") common stock, and may be settled, at the Company's option, in cash, shares of common stock, or a combination thereof. The RSUs vest in full on June 15, 2023, subject to continued service with the Company through the vesting date. Upon vesting, if settled in cash, each RSU will entitle the grantee to a cash-payment equal to the \"Fair Market Value\" (as defined in the Company's 2019 Equity Incentive Plan) of one share of the Company's common stock on the vesting date."}],"balance_after":42534,"source":{"system":"sec-edgar","filing":"0001062993-22-015134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000106299322015134/form4.xml","form_type":"4"}},{"id":2261781,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T21:37:16.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":118182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in full on May 18, 2023, subject to continued service with the Company."}],"balance_after":118182,"derivative":{"exercise_price":0.8,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":118182},"source":{"system":"sec-edgar","filing":"0001062993-22-013174","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000106299322013174/form4.xml","form_type":"4"}},{"id":2261780,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T21:37:16.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":87500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These restricted stock units will vest in full on May 18, 2023, subject to continued service with the Company. Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":167780,"source":{"system":"sec-edgar","filing":"0001062993-22-013174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000106299322013174/form4.xml","form_type":"4"}},{"id":2659653,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T16:51:32.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":67804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One third of the aggregate amount of option shares shall vest on each of June 17, 2022, 2023 and 2024, respectively."}],"balance_after":67804,"derivative":{"exercise_price":4.29,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":67804},"source":{"system":"sec-edgar","filing":"0001209191-21-042419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919121042419/doc4.xml","form_type":"4"}},{"id":2659652,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2021-06-22T16:51:32.000Z","date":"2021-06-18","kind":"sale","acquired":false,"shares":9000,"price":4.24,"value":38160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer."}],"balance_after":46943,"source":{"system":"sec-edgar","filing":"0001209191-21-042419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919121042419/doc4.xml","form_type":"4"}},{"id":2659651,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2021-06-22T16:51:32.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":14277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on the earlier of (1) June 17, 2022 or (2) the date of the company's 2022 Annual Meeting of Stockholders."}],"balance_after":55943,"source":{"system":"sec-edgar","filing":"0001209191-21-042419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919121042419/doc4.xml","form_type":"4"}},{"id":2710263,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-17T20:07:58.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":38012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amended Form 4 is being filed to correct a typographical error in the exercise price of the stock options acquired on April 20, 2021 as reported on the Form 4 filed on April 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on April 20, 2022."}],"balance_after":38012,"derivative":{"exercise_price":2.6,"expiration_date":"2031-04-20","underlying":"Common Stock","underlying_shares":38012},"source":{"system":"sec-edgar","filing":"0001192482-21-000434","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248221000434/edgar.xml","form_type":"4/A","original_submission_date":"2021-04-22"}},{"id":2741893,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-22T21:55:04.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":38012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on April 20, 2022."}],"balance_after":38012,"derivative":{"exercise_price":1.71,"expiration_date":"2031-04-20","underlying":"Common Stock","underlying_shares":38012},"source":{"system":"sec-edgar","filing":"0001192482-21-000347","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248221000347/edgar.xml","form_type":"4"}},{"id":2741892,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-22T21:55:04.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":26923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on April 20, 2022. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":80280,"source":{"system":"sec-edgar","filing":"0001192482-21-000347","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248221000347/edgar.xml","form_type":"4"}},{"id":2752894,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-08T23:04:09.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on April 7, 2022."}],"balance_after":83333,"derivative":{"exercise_price":1.24,"expiration_date":"2031-04-07","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001192482-21-000327","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248221000327/edgar.xml","form_type":"4"}},{"id":2752893,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-08T23:04:09.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":56452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on April 7, 2022. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":107185,"source":{"system":"sec-edgar","filing":"0001192482-21-000327","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248221000327/edgar.xml","form_type":"4"}},{"id":3102444,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T16:30:11.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"This stock option grant was previously reported on a Form 4 on June 19, 2020.  This is an amendment to that Form 4 to reflect an inadvertent error in Column 7 under the \"Amount or Number of Shares\"."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One third of the aggregate amount of option shares shall vest on each of June 18, 2021, 2022 and 2023, respectively."}],"balance_after":60000,"derivative":{"exercise_price":2.94,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-038471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120038471/doc4.xml","form_type":"4"}},{"id":3102443,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-06-23T16:30:11.000Z","date":"2020-06-22","kind":"sale","acquired":false,"shares":5000,"price":3.25,"value":16250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer."}],"balance_after":41666,"source":{"system":"sec-edgar","filing":"0001209191-20-038471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120038471/doc4.xml","form_type":"4"}},{"id":3104770,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T16:48:11.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the aggregate amount of option shares shall vest on each of June 18, 2021, 2022 and 2023, respectively."}],"balance_after":60000,"derivative":{"exercise_price":2.94,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-037973","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120037973/doc4.xml","form_type":"4"}},{"id":3104769,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-06-19T16:48:11.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on the earlier of (1) June 18, 2021 or (2) the date of the company's 2021 Annual Meeting of Stockholders."}],"balance_after":46666,"source":{"system":"sec-edgar","filing":"0001209191-20-037973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120037973/doc4.xml","form_type":"4"}},{"id":3154329,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-11T21:04:26.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":12405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 7, 2021."}],"balance_after":12405,"derivative":{"exercise_price":8.37,"expiration_date":"2030-05-07","underlying":"Common Stock","underlying_shares":12405},"source":{"system":"sec-edgar","filing":"0001192482-20-000338","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248220000338/edgar.xml","form_type":"4"}},{"id":3154328,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-11T21:04:26.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":8363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 7, 2021. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":53357,"source":{"system":"sec-edgar","filing":"0001192482-20-000338","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248220000338/edgar.xml","form_type":"4"}},{"id":3156314,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-09T00:19:25.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":34574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 6, 2021."}],"balance_after":34574,"derivative":{"exercise_price":3.05,"expiration_date":"2030-05-06","underlying":"Common Stock","underlying_shares":34574},"source":{"system":"sec-edgar","filing":"0001192482-20-000333","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248220000333/edgar.xml","form_type":"4"}},{"id":3156313,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-09T00:19:25.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":22951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 6, 2021. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":50733,"source":{"system":"sec-edgar","filing":"0001192482-20-000333","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248220000333/edgar.xml","form_type":"4"}},{"id":3348128,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T23:38:59.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":17582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in full on the earlier of (i) a change of control of Recro Pharma, Inc. (the \"Company\") (as defined in the Company's 2018 Amended and Restated Equity Incentive Plan) or (ii) December 5, 2020, subject to continued service with the Company."}],"balance_after":44994,"source":{"system":"sec-edgar","filing":"0001192482-19-000499","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248219000499/edgar.xml","form_type":"4"}},{"id":3348127,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T23:21:07.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are scheduled to vest 50% each on December 5, 2020 and December 5, 2021, subject to continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes common stock acquired pursuant to a special dividend issued on November 21, 2019, whereby all holders of common stock of Recro Pharma, Inc., as of November 15, 2019, received a dividend of one (1) share of Baudax Bio, Inc. common stock for every two and one-half (2.5) shares of Recro Pharma, Inc. common stock."}],"balance_after":27782,"source":{"system":"sec-edgar","filing":"0001192482-19-000480","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248219000480/edgar.xml","form_type":"4"}},{"id":3481980,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T20:02:35.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the option shares vested on June 20, 2019.  The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years."}],"balance_after":20000,"derivative":{"exercise_price":8.44,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-038664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119038664/doc4.xml","form_type":"4"}},{"id":3481979,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-06-21T20:02:35.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the restricted shares shall vest on the earlier of (1) June 20, 2020 or (2) the date of the company's 2020 Annual Meeting of Stockholders."}],"balance_after":16666,"source":{"system":"sec-edgar","filing":"0001209191-19-038664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119038664/doc4.xml","form_type":"4"}},{"id":3481978,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-06-21T20:02:35.000Z","date":"2019-06-20","kind":"sale","acquired":false,"shares":1667,"price":8.5,"value":14169.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 18, 2019."}],"balance_after":6666,"source":{"system":"sec-edgar","filing":"0001209191-19-038664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119038664/doc4.xml","form_type":"4"}},{"id":3481977,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-06-21T20:02:35.000Z","date":"2019-06-19","kind":"sale","acquired":false,"shares":5000,"price":8.59,"value":42950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 18, 2019."}],"balance_after":8333,"source":{"system":"sec-edgar","filing":"0001209191-19-038664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119038664/doc4.xml","form_type":"4"}},{"id":3531518,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-10T20:27:44.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":10888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 9, 2020."}],"balance_after":10888,"derivative":{"exercise_price":8.8,"expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":10888},"source":{"system":"sec-edgar","filing":"0001192482-19-000248","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248219000248/edgar.xml","form_type":"4"}},{"id":3531517,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T20:27:44.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":7955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 9, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":27412,"source":{"system":"sec-edgar","filing":"0001192482-19-000248","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248219000248/edgar.xml","form_type":"4"}},{"id":3746871,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-03T19:54:27.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shares vested on November 30, 2018.  The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years."}],"balance_after":6667,"derivative":{"exercise_price":14.02,"expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001209191-18-060692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118060692/doc4.xml","form_type":"4"}},{"id":3746870,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-12-03T19:54:27.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on June 19, 2019."}],"balance_after":13333,"source":{"system":"sec-edgar","filing":"0001209191-18-060692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118060692/doc4.xml","form_type":"4"}},{"id":3889754,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-19T18:28:11.000Z","date":"2018-06-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shares vested on June 18, 2018.  The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years."}],"balance_after":20000,"derivative":{"exercise_price":19.95,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-038665","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118038665/doc4.xml","form_type":"4"}},{"id":3889753,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-06-19T18:28:11.000Z","date":"2018-06-18","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on the earlier of (1) June 18, 2019 or (2) the date of the company's 2019 Annual Meeting of Stockholders."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-18-038665","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118038665/doc4.xml","form_type":"4"}},{"id":3934734,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-14T20:57:27.000Z","date":"2018-05-12","kind":"exercise","acquired":false,"shares":13274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 12, 2017, the reporting person was granted 13,274 restricted stock units, vesting on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 12, 2017, the reporting person was granted 13,274 restricted stock units, vesting on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13274},"source":{"system":"sec-edgar","filing":"0001192482-18-000209","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248218000209/edgar.xml","form_type":"4"}},{"id":3934733,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-14T20:57:27.000Z","date":"2018-05-12","kind":"exercise","acquired":true,"shares":13274,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":19457,"source":{"system":"sec-edgar","filing":"0001192482-18-000209","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248218000209/edgar.xml","form_type":"4"}},{"id":3938926,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-10T23:00:55.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":8965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amended Form 4 is being filed to correct a typographical error in the number of stock options acquired on May 4, 2018 as reported on the Form 4 filed on May 8, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 4, 2019."}],"balance_after":8965,"derivative":{"exercise_price":11.32,"expiration_date":"2028-05-04","underlying":"Common Stock","underlying_shares":8965},"source":{"system":"sec-edgar","filing":"0001192482-18-000198","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248218000198/edgar.xml","form_type":"4/A","original_submission_date":"2018-05-08"}},{"id":3942515,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-08T21:29:31.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":5742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 4, 2019."}],"balance_after":5742,"derivative":{"exercise_price":11.32,"expiration_date":"2028-05-04","underlying":"Common Stock","underlying_shares":5742},"source":{"system":"sec-edgar","filing":"0001192482-18-000186","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248218000186/edgar.xml","form_type":"4"}},{"id":3942514,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-08T21:29:31.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":6183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 4, 2019. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":6183,"source":{"system":"sec-edgar","filing":"0001192482-18-000186","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000119248218000186/edgar.xml","form_type":"4"}},{"id":4189069,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-10T21:48:56.000Z","date":"2017-10-10","kind":"grant","acquired":true,"shares":15472,"price":0.38,"value":5879.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective January 1, 2017, 33% of the cash retainer payments to our Board will be paid in unrestricted shares of the Company's common stock, delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing stock price of the Company's stock on the first trading day of the quarter."}],"balance_after":38154,"source":{"system":"sec-edgar","filing":"0001394548-17-000028","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000139454817000028/primary_doc.xml","form_type":"4"}},{"id":4261888,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-06T21:44:33.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's 2016 Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option will vest and become exercisable in equal quarterly installments over one year beginning three months from June 8, 2017, such that the option will be fully exercisable as of June 8, 2018."}],"balance_after":5000,"derivative":{"exercise_price":0.55,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001394548-17-000025","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000139454817000025/primary_doc.xml","form_type":"4"}},{"id":4261887,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-06T21:44:33.000Z","date":"2017-07-06","kind":"grant","acquired":true,"shares":9866,"price":0.59,"value":5820.94,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective January 1, 2017, 33% of the cash retainer payments to our Board will be pain in unrestricted shares of the Company's common stock delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing stock price of the Company's stock on the first trading day of the quarter."}],"balance_after":22682,"source":{"system":"sec-edgar","filing":"0001394548-17-000025","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000139454817000025/primary_doc.xml","form_type":"4"}},{"id":4318414,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-16T20:27:59.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":13274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 12, 2018. Vested shares will be delivered to the reporting person within 30 days following the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 12, 2018. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":13274,"derivative":{"underlying":"Common Stock","underlying_shares":13274},"source":{"system":"sec-edgar","filing":"0001123292-17-000939","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000112329217000939/edgar.xml","form_type":"4"}},{"id":4353463,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-12T20:53:16.000Z","date":"2017-04-10","kind":"grant","acquired":true,"shares":9870,"price":0.59,"value":5823.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective January 1, 2017, 33% of the cash retainer payments to our Board will be paid in unrestricted shares of the Company's common stock, delivered from the 2016 Incentive Plan, priced on the first trading day of the quarter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing stock price of the Company's stock on the first trading day of the quarter."}],"balance_after":12816,"source":{"system":"sec-edgar","filing":"0001394548-17-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000139454817000012/primary_doc.xml","form_type":"4"}},{"id":4482975,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":41400,"kind":"person","name":"Ashton William","position":1,"cik":"0001474553","reported_name":"Ashton William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-24T23:07:44.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":2946,"price":1.98,"value":5833.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Effective January 1, 2017, 33% of the cash retainer payments to our Board will be paid in unrestricted shares of the Company's common stock, delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing stock price of the Company's stock on the first trading day of the quarter."}],"balance_after":2946,"source":{"system":"sec-edgar","filing":"0001394548-17-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474553/000139454817000008/primary_doc.xml","form_type":"4"}}]}